Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9717740 | ETON | Treatment of adrenal insufficiency |
Nov, 2032
(8 years from now) | |
US9675559 | ETON | Treatment of adrenal insufficiency |
Jan, 2033
(8 years from now) | |
US9649280 | ETON | Composition comprising hydrocortisone |
May, 2034
(10 years from now) |
Drugs and Companies using HYDROCORTISONE ingredient
Market Authorisation Date: 29 September, 2020
Treatment: Treatment of adrenal insufficiency
Dosage: GRANULE;ORAL